SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) Trading Down 1.4% – Should You Sell?

SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH)’s stock price fell 1.4% on Friday . The stock traded as low as $58.79 and last traded at $58.88. 14,808 shares were traded during mid-day trading, a decline of 83% from the average session volume of 86,136 shares. The stock had previously closed at $59.74.

SPDR S&P Pharmaceuticals ETF Stock Down 1.4%

The firm has a market cap of $362.11 million, a PE ratio of 14.28 and a beta of 0.61. The company’s fifty day moving average price is $55.85 and its two-hundred day moving average price is $54.92.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in XPH. Turtle Creek Wealth Advisors LLC acquired a new position in SPDR S&P Pharmaceuticals ETF during the first quarter worth about $26,000. Advisory Services Network LLC acquired a new position in SPDR S&P Pharmaceuticals ETF during the third quarter worth about $34,000. Fifth Third Bancorp acquired a new position in SPDR S&P Pharmaceuticals ETF during the first quarter worth about $39,000. Team Financial Group LLC acquired a new position in SPDR S&P Pharmaceuticals ETF during the fourth quarter worth about $56,000. Finally, Kestra Advisory Services LLC acquired a new position in SPDR S&P Pharmaceuticals ETF during the fourth quarter worth about $151,000.

SPDR S&P Pharmaceuticals ETF Company Profile

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.